Last update 08 May 2025

KP-405

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
GIPR x GLP-1R
Action
agonists
Mechanism
GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication
Parkinson DiseaseAlzheimer Disease
Inactive Indication-
Originator Organization
Kariya Pharmaceuticals ApSKariya Pharmaceuticals ApS
Active Organization
Kariya Pharmaceuticals ApSKariya Pharmaceuticals ApS
Inactive Organization-
License Organization
Kariya Pharmaceuticals ApSKariya Pharmaceuticals ApSBNC KOREA, Inc.BNC KOREA, Inc.
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with KP-405
NCT06189170
/ RecruitingEarly Phase 1
A Phase I, Randomised, Double-Blinded, Placebo-Controlled Study to Evaluate KP405. Part 1: Single Ascending Dosing in Healthy Participants. Part 2: Multiple Ascending Dosing in Healthy Participants and Parkinson's Disease Patients.
100 Clinical Results associated with KP-405
Login to view more data
100 Translational Medicine associated with KP-405
Login to view more data
100 Patents (Medical) associated with KP-405
Login to view more data
100 Deals associated with KP-405
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 1
United Kingdom
Kariya Pharmaceuticals ApSKariya Pharmaceuticals ApS
01 Aug 2024
Alzheimer DiseasePreclinical
Denmark
Kariya Pharmaceuticals ApSKariya Pharmaceuticals ApS
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free